Αποτελέσματα Αναζήτησης
1 Σεπ 2014 · The original Hepatix, Inc (Houston, TX), device supported dogs with lethal acetaminophen-induced liver failure until their native livers had recovered, and they were able to survive without further support. 11, 20 The original device also appeared to be effective in supporting 23 patients with ALF. 14, 15 The modified device was tested in 5 ...
1 Νοε 1998 · Abstract. During the past decade, whole organ transplantation has become the only clinically effective method of treating fulminant hepatic failure and chronic liver failure due to specific genetic, hepatocellular, and anatomic defects of liver function.
Bioartificial liver (BAL) support systems have a potential effect to provide temporary support to bridge patients with acute liver failure to liver transplantation or spontaneous recovery. In the past decades, several BAL support systems have been conducted in clinical trials, but remained verified.
18 Φεβ 2021 · Considering hepatic encephalopathy, extracorporeal liver assist device (ELAD) may be the most effective option (SUCRA: 78%).
Abstract: We have used an anhepatic dog model to demonstrate the efficacy of a bioartificial liver assist device. Six dogs underwent total hepatectomy. Three received only medical care (controls) while the remainder were connected to an extracorporeal liver assist device (ELAD).
Not all pets with increased ALP or ALT have significant liver disease. Some changes are transient, and caused by an acute insult such as trauma, ingestion of something mildly toxic, or medication. The liver has an amazing ability to regenerate, so often small injuries will resolve in time.
1 Απρ 1999 · In this report, the design of a scaled-up PUF-HAL for dogs is described and evaluated using a dog acute liver failure model. METHODS Warm ischemic liver failure was induced with a portocaval shunt in each dog.
